MarketScreener Homepage > Equities > Deutsche Boerse AG > HumanOptics AG H9O1 DE000A1MMCR6

Delayed Deutsche Boerse AG - 10/17 03:43:41 am
12.5	EUR		-8.42%

08/30

HUMANOPTICS AG : Majority stake in HumanOptics AG to be sold to Chinese investor

2018

HUMANOPTICS AG : Capital increase from authorized capital planned with exclusion of subscription rights; sustainable strengthening of equity base through conversion of liabilities

2018

HUMANOPTICS : Artificial Iris of HumanOptics Received FDA Approval

Summary

Quotes 5-day view Delayed Quote.

Delayed Deutsche Boerse Ag

10/11/2019	10/14/2019	10/15/2019	10/16/2019	10/17/2019	Date
13.35(c)	12.65(c)	14.3(c)	13.65(c)	12.5	Last
0	100	200	0	200	Volume
-4.64%	-5.24%	+13.04%	-4.55%	-8.42%	Change

More quotes

Company

HumanOptics AG is a Germany-based company that develops, produces and distributes intelligent technology for eye implantation surgery, especially intraocular lenses (IOL). These artificial lenses are implanted into the human eye. Indications for IOL implantations are eye diseases, such as the...

Sector

Medical Equipment, Supplies & Distribution

Calendar

More about the company

Latest news on HUMANOPTICS AG

08/30	HUMANOPTICS AG : Majority stake in HumanOptics AG to be sold to Chinese investor	EQ
2018	HUMANOPTICS AG : Capital increase from authorized capital planned with exclusion..	EQ
2018	HUMANOPTICS : Artificial Iris of HumanOptics Received FDA Approval	PU
2018	HUMANOPTICS : Artificial Iris of HumanOptics Received FDA Approval	EQ

More news

News in other languages on HUMANOPTICS AG

08/30	HUMANOPTICS AG : Verkauf der Mehrheitsbeteiligung an HumanOptics AG an chinesisc..
08/30	HUMANOPTICS AG : Verkauf der Mehrheitsbeteiligung an HumanOptics AG an chinesisc..
08/09	HUMANOPTICS AG : Kapitalerhöhung aus genehmigten Kapital unter Bezugsrechtsaussc..
08/09	HUMANOPTICS AG : Kapitalerhöhung aus genehmigten Kapital unter Bezugsrechtsaussc..
2018	HUMANOPTICS AG : Kapitalerhöhung aus genehmigten Kapital unter Bezugsrechtsaussc..

More news

Sector news : Medical Equipment, Supplies & Distribution - NEC

05:25a	Teva to donate over $15 billion worth of drugs in opioid settlement - source	RE
10/16	DRUG FIRMS OFFER TO SETTLE U.S. OPIO : sources	RE
10/16	A selection of British stocks to play the Brexit game
10/16	Johnson & Johnson Shares Rise	DJ
10/16	GLOBAL MARKETS LIVE : Roche, Bank of America, Alphabet, MGM…

More sector news : Medical Equipment, Supplies & Distribution - NEC

Chart HUMANOPTICS AG

Duration : Period :

HumanOptics AG Technical Analysis Chart | MarketScreener

Full-screen chart

Managers

Name	Title
Pierre Billardon	Chief Executive Officer
Sonja Strauß	Chairman-Supervisory Board
Robert Schäfer	Vice Chairman-Supervisory Board
Eckhard Besuden	Member-Supervisory Board
Ursula Schwarzmann	Head-Sales Germany Area North-East

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

HUMANOPTICS AG	-31.75%	47



MEDTRONIC PLC	19.28%	145 571
BAXTER INTERNATIONAL INC.	32.21%	44 429
HOYA CORPORATION	43.75%	32 180
ZIMMER BIOMET HOLDINGS	31.68%	28 042
TERUMO CORPORATION	-42.91%	23 709

More Results